Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?
Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, et al.
Gut (2022) Vol. 72, Iss. 1, pp. 192-204
Closed Access | Times Cited: 20

Showing 20 citing articles:

Data analytics in healthcare: A review of patient-centric approaches and healthcare delivery
Chidera Victoria Ibeh, Oluwafunmi Adijat Elufioye, Temidayo Olorunsogo, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 21, Iss. 2, pp. 1750-1760
Open Access | Times Cited: 26
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 5
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies
Bénédicte Caron, Sailish Honap, Laurent Peyrin-Biroulet
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii3-ii15
Open Access | Times Cited: 12
Treat to target in Crohn’s disease: A practical guide for clinicians
Ashish Srinivasan
World Journal of Gastroenterology (2024) Vol. 30, Iss. 1, pp. 50-69
Open Access | Times Cited: 11
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances
Shumeng Hu, Runan Zhao, Yu Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 1, pp. 13-38
Closed Access | Times Cited: 15
Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study
Henit Yanai, Nir Salomon, Adi Lahat, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 2, pp. 175-181
Open Access | Times Cited: 12
Non-Adherence Rate to Oral Mesalamine in Ulcerative Colitis Patients: A Systematic Review with Meta-Analysis
Cristiano Pagnini, Elisabetta Antonelli, B. Scrivo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 123-123
Open Access
In situ delivered chitosan-encapsulated hydrogen microbubbles for inflammatory bowel disease therapy by scavenging oxidative stress
T. Liu, Jinxing Song, Wenxian Zhang, et al.
Materials & Design (2025), pp. 113951-113951
Open Access
Research advancements and perspectives of inflammatory bowel disease: A comprehensive review
JingShan Bai, Ying Wang, Fuhao Li, et al.
Science Progress (2024) Vol. 107, Iss. 2
Open Access | Times Cited: 3
Monitoring of patients with active inflammatory bowel disease
Torsten Kucharzik, Bram Verstockt, Christian Maaser
Frontiers in Gastroenterology (2023) Vol. 2
Open Access | Times Cited: 8
Investigating the Crime Scene—Molecular Signatures in Inflammatory Bowel Disease
Vibeke Andersen, Tue Bjerg Bennike, Corinna Bang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11217-11217
Open Access | Times Cited: 7
Using Participatory Narrative Inquiry to Assess Experiences and Self-Experimentation with Diet Interventions in Inflammatory Bowel Disease Patients
Celine Hos, Merel Tebbens, Tjitske Bezema, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4027-4027
Open Access | Times Cited: 2
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts
Eran Zittan, Hussein Mahajna, Nir Salomon
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 9, pp. e35-e36
Closed Access | Times Cited: 1
Association between body fat composition and disease duration, clinical activity, and intravenous corticosteroid-induced response in inflammatory bowel disease
Shubei He, Yuxia Huang, Ying Peng, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Patient-Centric Approaches: Revolutionizing Rare Disease Drug Research
Abhishek Verma, Ankit Awasthi
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 8
Closed Access
Self‐employed people with chronic health conditions: Business maintenance and well‐being
Wafaa Sowan, Dana Yagil, Miri Cohen
Stress and Health (2024) Vol. 40, Iss. 5
Open Access
Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experiment
Elise Schoefs, Séverine Vermeire, Marc Ferrante, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
The application of the combination between artificial intelligence and endoscopy in gastrointestinal tumors
Li Shen, Maosen Xu, Yuanling Meng, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
Recent advances in clinical practice: mastering the challenge—managing IBS symptoms in IBD
Judith Wellens, João Sabino, Tim Vanuytsel, et al.
Gut (2024), pp. gutjnl-333565
Closed Access
Inflammatory bowel disease in STAT1 gain-of-function immunodeficiency treated with precision medicine
Julian Schwärzler, A Zollner, Theresa Dolejsi, et al.
Gut (2023) Vol. 73, Iss. 8, pp. 1394-1396
Closed Access
Page 1

Scroll to top